HERTFORDSHIRE, England and PITTSBURGH and NEW YORK, March 26, 2020 /PRNewswire/ -- Mylan N.V. (Nasdaq: MYL) and Pfizer Inc. (NYSE: PFE) today announced that due to the unprecedented circumstances surrounding the COVID-19 pandemic, including associated delays in the regulatory review process, the proposed t

ZURICH, March 26, 2020 /PRNewswire/ -- RELIEF THERAPEUTICS Holding AG (SIX: RLF) "Relief", together with NeuroRx, a Delaware Corporation, have filed an Investigational New Drug (IND) Application with the US FDA for a phase 2 trial of RLF-100 (Aviptadil) in the treatment of Acute and Moderate Respiratory Distress in patients infected by the COVID-19 coronaviru

SHANGHAI, March 26, 2020 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX: 2616), a leading biopharmaceutical company focused on developing and commercializing innovative immuno-oncology (IO) therapies and molecularly-targeted precision medicines for the treatment of cancer, today released its audited annual financial results for the year ended

ARLINGTON, Va., March 26, 2020 /PRNewswire/ -- The National Council on Aging (NCOA) is partnering with Lyft to meet the critical transportation needs of caregivers who are supporting homebound older adults during the COVID-19 outbreak.

FAYETTEVILLE, N.C., March 26, 2020 /PRNewswire/ -- Cyto CBD, the CBD company that created precision medical dosing, is partnering with Cumberland Medical Associates and Purple Lotus Aesthetics to help transition patients from opioid-focused treatments to Cannabidiol (CBD) for chronic pain management.

KRAKOW, Poland, March 26, 2020 /PRNewswire/ -- Selvita S.A. (WSE: SLV) – one of the largest preclinical contract research organizations in Europe – reported today its annual financial results for 2019 and provided a corporate update.The total commercial revenues of the services

STOCKHOLM, March 26, 2020 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announces today the final topline results from the pivotal phase 2 HORIZON study evaluating melflufen in relapsed refractory multiple myeloma (RRMM) patients. These results will form the basis for the upcoming NDA for accelerated approval in

BOCA RATON, Florida, March 26, 2020 /PRNewswire/ -- StemSation International, Inc. (OTC PINK: STSN) – a pioneer in the emerging category of dietary supplements called Stem Cell Nutrition, announces its home-based business model provides an opportunity for a primary or secondary source of income by utilizing web-based audio and video conferencing too

TOKYO, March 26, 2020 /PRNewswire/ -- Nippon Express Co., Ltd., has received Good Distribution Practice (GDP) certification indicating compliance with industry-accepted standards for the proper distribution of pharmaceutical products for its in-transit air cargo storage services at the Narita Temperature Controlled Hub ("NTCH"), a temperature-controlled facility within a

SEATTLE and BRISBANE, Australia, March 26, 2020 /PRNewswire/ -- Immunexpress, Inc. a molecular diagnostic company focused on improving outcome